The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Actionability landscape and biomarker utility in a colorectal cancer alliance cohort: Initial results from the Know Your Biomarker program.
 
Patricia de Arbeloa
Employment - Perthera
 
Edik Blais
Employment - Biogen (I); Perthera
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
Research Funding - Perthera (Inst)
Patents, Royalties, Other Intellectual Property - Perthera
 
Raymond Wadlow
Honoraria - Astellas Pharma; Oncocyte; Pfizer; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Johnson & Johnson (I)
 
Jennifer Chuy
Other Relationship - Loki Therapeutics
 
Naoko Takebe
No Relationships to Disclose
 
Patrick Boland
Consulting or Advisory Role - Abbvie; BeiGene; Bristol Myers Squibb Foundation; Taiho Oncology
Research Funding - Caris Life Sciences (Inst); Compass Therapeutics (Inst); MEI Pharma (Inst); Merck (Inst); Processa Pharmaceuticals (Inst)
 
Dzung Thach
Employment - Perthera
Stock and Other Ownership Interests - Perthera
 
David Lieberman
No Relationships to Disclose
 
Michael Pishvaian
Stock and Other Ownership Interests - Perthera; Targeting Resistance in Cancer Cooperative; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; Merck; Merus; Moderna Therapeutics; Pfizer; Renovo Rx; Seagen; Serna Bio; TriSalus Life Sciences
Research Funding - Actuate Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Elevation Oncology (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Recursion Pharmaceuticals (Inst); Repare Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Astellas Pharma; Merus; RenovoRx
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Ceres Nanosciences; Perthera
Consulting or Advisory Role - Ceres Nanosciences; DAiNA, Inc.; Ignite Proteomics, Inc.; Perthera; Targeted Biosciences, Inc.
Research Funding - Ceres Nanosciences (Inst); Deciphera; G1 Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst); SpringWorks Therapeutics
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera